Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery?

A best evidence topic in paediatric cardiac surgery was written according to a structured protocol. The question addressed was whether recombinant activated factor VII was effective for the treatment of excessive bleeding after paediatric cardiac surgery. Altogether 150 papers were found using the r...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Interactive cardiovascular and thoracic surgery 2012-10, Vol.15 (4), p.690-694
Hauptverfasser:	Okonta, Kelechi E., Edwin, Frank, Falase, Bode
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Age Factors Benchmarking Best Evidence Topics Blood Coagulation - drug effects Cardiac Surgical Procedures - adverse effects Child Child, Preschool Coagulants - adverse effects Coagulants - therapeutic use Evidence-Based Medicine Factor VIIa - adverse effects Factor VIIa - therapeutic use Heart Defects, Congenital - surgery Hemostatic Techniques - adverse effects Humans Infant Infant, Newborn Postoperative Hemorrhage - blood Postoperative Hemorrhage - drug therapy Postoperative Hemorrhage - etiology Recombinant Proteins - adverse effects Recombinant Proteins - therapeutic use Risk Assessment Risk Factors Treatment Outcome
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!